Melanoma

Most recent

Twitter feed

RT @NatureNews: In the age of immunotherapy, cancer biologists are relying on a new generation of tools to learn how the interplay between…
h J R
Video: Dr. Mark Vincent Discusses Outcomes in Pancreatic Adenocarcinoma Patients with Genetic Alterations in DNA Da… https://t.co/35E7MSeX3V
h J R
RT @medoncdoc: CO26. first evidence of survival benefit in MSS patients using immunotherapy. 6.6 mo vs 4.1 mo.#GI19 @CDNCancerTrials great…
h J R
RT @tehfem: Adjuvant HIPEC in CRC at high risk for peritoneal mets No benefit #GI19 https://t.co/tYIw9B3eme
h J R
RT @GillSharlene: How long to optimally wait for resection after neoadjuvant therapy for early stage rectal cancer? Looks like the answer…
h J R

Other

Canadian perspective by Dr. Teresa Petrella

September 2011 ASCO 2011 New Treatment Strategies and Ongoing Clinical Research for Metastatic Melanoma Metastatic melanoma is a devastating disease with a very poor prognosis and historically, therapeutic options have been limited. However, new agents and treatment...

Canadian Perspective on the Clinical Management of Metastatic Melanoma

NE Oncology Issue - September 2012 Teresa Petrella, MD, FRCPC;1 Scott Ernst, MD, FRCPC;2 Alan Spatz, MD;3 Joel Claveau, MD, FRCPC;4 Ralph Wong, BSc, MD, FRCPC;5 Michael Smylie, MD, FRCPC6 1Division of Medical Oncology/Hematology, Odette Cancer Centre, Toronto,...

Twitter feed

RT @NatureNews: In the age of immunotherapy, cancer biologists are relying on a new generation of tools to learn how the interplay between…
h J R
Video: Dr. Mark Vincent Discusses Outcomes in Pancreatic Adenocarcinoma Patients with Genetic Alterations in DNA Da… https://t.co/35E7MSeX3V
h J R
RT @medoncdoc: CO26. first evidence of survival benefit in MSS patients using immunotherapy. 6.6 mo vs 4.1 mo.#GI19 @CDNCancerTrials great…
h J R
RT @tehfem: Adjuvant HIPEC in CRC at high risk for peritoneal mets No benefit #GI19 https://t.co/tYIw9B3eme
h J R
RT @GillSharlene: How long to optimally wait for resection after neoadjuvant therapy for early stage rectal cancer? Looks like the answer…
h J R